The medical high pressure syringe market size has grown strongly in recent years. It will grow from $1.64 billion in 2025 to $1.77 billion in 2026 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to growth of CT and MRI scans, expansion of diagnostic centers, need for accurate contrast dosing, radiology workflow standardization, hospital imaging upgrades.
The medical high pressure syringe market size is expected to see strong growth in the next few years. It will grow to $2.4 billion in 2030 at a compound annual growth rate (CAGR) of 8%. The growth in the forecast period can be attributed to growth of minimally invasive diagnostics, expansion of imaging infrastructure, technological advancement in injectors, demand for faster imaging procedures, rising chronic disease diagnostics. Major trends in the forecast period include rising use in advanced diagnostic imaging, demand for high-precision contrast delivery, growth of syringeless injector compatibility, increased focus on patient safety, adoption of disposable high-pressure syringes.
The rising demand for minimally invasive procedures is expected to drive the growth of the medical high-pressure syringes market in the near future. Minimally invasive procedures involve medical techniques that utilize small incisions or non-invasive methods to perform surgeries or treatments, resulting in less tissue damage, shorter recovery periods, and reduced postoperative pain compared to conventional surgical methods. The increase in these procedures is fueled by patients seeking quicker recovery and less invasive alternatives, as they generally lead to shorter hospital stays, fewer complications, and faster return to normal activities. Medical high-pressure syringes play a crucial role in supporting these procedures by delivering contrast media with precision and control, which is essential for accurate imaging and effective intervention. For example, in February 2024, the American Academy of Facial Plastic and Reconstructive Surgery, a US-based nonprofit organization, reported that 83% of all medical procedures performed in 2023 were minimally invasive, while only 17% were traditional surgeries. Additionally, the American Society of Plastic Surgeons, a US-based specialty group, noted that cosmetic minimally invasive procedures rose from 23.7 million in 2022 to 25.4 million in 2023. As a result, the increasing preference for minimally invasive procedures is significantly boosting the demand for medical high-pressure syringes.
Key players in the medical high-pressure syringes market are emphasizing the development of advanced technologies, such as needle-free systems, to improve patient safety and increase injection efficiency. Needle-free technology allows for the delivery of medications or fluids without traditional needles, aiming to reduce pain, lower the risk of infection, and encourage better patient compliance. For instance, in November 2024, Sol-Millennium Medical Group, a US-based medical company, launched a groundbreaking needle-free injection device for insulin delivery in Canada. This innovative solution is specifically designed to enhance patient comfort by eliminating the pain and fear typically associated with needle-based injections. Utilizing high-pressure technology, the device delivers insulin through the skin without piercing it. This advancement represents a major step forward in diabetes management, providing a more comfortable and accessible option for insulin users. The launch also signifies Sol-Millennium’s strategic expansion into the Canadian medical device market.
In May 2024, Nordson Corporation, a US-based precision technology company specializing in dispensing, fluid management, and medical device systems, acquired Atrion Corporation for approximately $800 million. Through this acquisition, Nordson aims to expand and strengthen its medical and fluid solutions portfolio by entering the infusion and high-precision fluid delivery systems segment, enhancing its capabilities in critical medical applications. Atrion Corporation is a US-based medical device company specializing in medical infusion fluid delivery products, including high-pressure syringes and cardiovascular inflation solutions.
Major companies operating in the medical high pressure syringe market are Cardinal Health Inc., Bayer AG, Medline Industries Inc., Becton Dickinson and Company, GE Healthcare Technologies Inc., Terumo Corporation, Gerresheimer AG, Merit Medical Systems Inc., MedNet GmbH, B. Braun Melsungen AG, Ulrich GmbH & Co. KG, Hawkmed (Shenzhen Hawk Medical Instrument Co. Ltd.), Kemper Medical Inc., Smiths Medical (ICU Medical Inc.), APOLLO RT Co. Ltd., Hindustan Syringes & Medical Devices Limited, Guerbet Group, Bracco Imaging S.p.A., Nemoto Kyorindo Co. Ltd., Medrad (Bayer Radiology), AngioDynamics Inc., Shenzhen Antmed Co. Ltd.
North America was the largest region in the medical high pressure Syringe market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical high pressure syringe market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the medical high pressure syringe market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have increased the cost of imported medical grade plastics, glass components, metal fittings, and electronic controls used in medical high pressure syringes and injector systems, raising overall device prices. These impacts are most pronounced in CT and MRI injector systems, particularly in Asia-Pacific and Europe where component sourcing is highly globalized. Higher costs have affected procurement by hospitals and diagnostic centers. However, tariffs have also encouraged domestic manufacturing and assembly of injector systems and syringes, strengthening regional supply chains and improving long term cost stability.
The medical high pressure syringe market research report is one of a series of new reports that provides medical high pressure syringe market statistics, including medical high pressure syringe industry global market size, regional shares, competitors with a medical high pressure syringe market share, detailed medical high pressure syringe market segments, market trends and opportunities, and any further data you may need to thrive in the medical high pressure syringe industry. This medical high pressure syringe market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A medical high-pressure syringe is a specialized device used to inject contrast agents during imaging procedures such as CT and MRI scans. It is engineered to withstand the high pressures necessary for the rapid and controlled delivery of fluids, ensuring accurate dosing and improved imaging quality for diagnostic accuracy.
The primary product types of medical high-pressure syringes include CT injector systems, MRI injector systems, and angiographic injector systems. These contrast injectors are medical devices specifically designed to deliver contrast media into the body to enhance tissue visibility during imaging procedures. They are manufactured using various materials such as plastic, glass, and metal. Medical high-pressure syringes are utilized in a range of applications, including cardiology, radiology, urology, and orthopedics. Key end users of these devices include hospitals, diagnostic centers, and ambulatory surgical centers.
The medical high pressure syringe market consists of sales of CT high-pressure syringes, angiographic syringes, and automated injector-compatible syringes. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The medical high pressure syringe market size is expected to see strong growth in the next few years. It will grow to $2.4 billion in 2030 at a compound annual growth rate (CAGR) of 8%. The growth in the forecast period can be attributed to growth of minimally invasive diagnostics, expansion of imaging infrastructure, technological advancement in injectors, demand for faster imaging procedures, rising chronic disease diagnostics. Major trends in the forecast period include rising use in advanced diagnostic imaging, demand for high-precision contrast delivery, growth of syringeless injector compatibility, increased focus on patient safety, adoption of disposable high-pressure syringes.
The rising demand for minimally invasive procedures is expected to drive the growth of the medical high-pressure syringes market in the near future. Minimally invasive procedures involve medical techniques that utilize small incisions or non-invasive methods to perform surgeries or treatments, resulting in less tissue damage, shorter recovery periods, and reduced postoperative pain compared to conventional surgical methods. The increase in these procedures is fueled by patients seeking quicker recovery and less invasive alternatives, as they generally lead to shorter hospital stays, fewer complications, and faster return to normal activities. Medical high-pressure syringes play a crucial role in supporting these procedures by delivering contrast media with precision and control, which is essential for accurate imaging and effective intervention. For example, in February 2024, the American Academy of Facial Plastic and Reconstructive Surgery, a US-based nonprofit organization, reported that 83% of all medical procedures performed in 2023 were minimally invasive, while only 17% were traditional surgeries. Additionally, the American Society of Plastic Surgeons, a US-based specialty group, noted that cosmetic minimally invasive procedures rose from 23.7 million in 2022 to 25.4 million in 2023. As a result, the increasing preference for minimally invasive procedures is significantly boosting the demand for medical high-pressure syringes.
Key players in the medical high-pressure syringes market are emphasizing the development of advanced technologies, such as needle-free systems, to improve patient safety and increase injection efficiency. Needle-free technology allows for the delivery of medications or fluids without traditional needles, aiming to reduce pain, lower the risk of infection, and encourage better patient compliance. For instance, in November 2024, Sol-Millennium Medical Group, a US-based medical company, launched a groundbreaking needle-free injection device for insulin delivery in Canada. This innovative solution is specifically designed to enhance patient comfort by eliminating the pain and fear typically associated with needle-based injections. Utilizing high-pressure technology, the device delivers insulin through the skin without piercing it. This advancement represents a major step forward in diabetes management, providing a more comfortable and accessible option for insulin users. The launch also signifies Sol-Millennium’s strategic expansion into the Canadian medical device market.
In May 2024, Nordson Corporation, a US-based precision technology company specializing in dispensing, fluid management, and medical device systems, acquired Atrion Corporation for approximately $800 million. Through this acquisition, Nordson aims to expand and strengthen its medical and fluid solutions portfolio by entering the infusion and high-precision fluid delivery systems segment, enhancing its capabilities in critical medical applications. Atrion Corporation is a US-based medical device company specializing in medical infusion fluid delivery products, including high-pressure syringes and cardiovascular inflation solutions.
Major companies operating in the medical high pressure syringe market are Cardinal Health Inc., Bayer AG, Medline Industries Inc., Becton Dickinson and Company, GE Healthcare Technologies Inc., Terumo Corporation, Gerresheimer AG, Merit Medical Systems Inc., MedNet GmbH, B. Braun Melsungen AG, Ulrich GmbH & Co. KG, Hawkmed (Shenzhen Hawk Medical Instrument Co. Ltd.), Kemper Medical Inc., Smiths Medical (ICU Medical Inc.), APOLLO RT Co. Ltd., Hindustan Syringes & Medical Devices Limited, Guerbet Group, Bracco Imaging S.p.A., Nemoto Kyorindo Co. Ltd., Medrad (Bayer Radiology), AngioDynamics Inc., Shenzhen Antmed Co. Ltd.
North America was the largest region in the medical high pressure Syringe market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical high pressure syringe market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the medical high pressure syringe market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have increased the cost of imported medical grade plastics, glass components, metal fittings, and electronic controls used in medical high pressure syringes and injector systems, raising overall device prices. These impacts are most pronounced in CT and MRI injector systems, particularly in Asia-Pacific and Europe where component sourcing is highly globalized. Higher costs have affected procurement by hospitals and diagnostic centers. However, tariffs have also encouraged domestic manufacturing and assembly of injector systems and syringes, strengthening regional supply chains and improving long term cost stability.
The medical high pressure syringe market research report is one of a series of new reports that provides medical high pressure syringe market statistics, including medical high pressure syringe industry global market size, regional shares, competitors with a medical high pressure syringe market share, detailed medical high pressure syringe market segments, market trends and opportunities, and any further data you may need to thrive in the medical high pressure syringe industry. This medical high pressure syringe market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A medical high-pressure syringe is a specialized device used to inject contrast agents during imaging procedures such as CT and MRI scans. It is engineered to withstand the high pressures necessary for the rapid and controlled delivery of fluids, ensuring accurate dosing and improved imaging quality for diagnostic accuracy.
The primary product types of medical high-pressure syringes include CT injector systems, MRI injector systems, and angiographic injector systems. These contrast injectors are medical devices specifically designed to deliver contrast media into the body to enhance tissue visibility during imaging procedures. They are manufactured using various materials such as plastic, glass, and metal. Medical high-pressure syringes are utilized in a range of applications, including cardiology, radiology, urology, and orthopedics. Key end users of these devices include hospitals, diagnostic centers, and ambulatory surgical centers.
The medical high pressure syringe market consists of sales of CT high-pressure syringes, angiographic syringes, and automated injector-compatible syringes. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Medical High Pressure Syringe Market Characteristics
3. Medical High Pressure Syringe Market Supply Chain Analysis
4. Global Medical High Pressure Syringe Market Trends and Strategies
5. Medical High Pressure Syringe Market Analysis of End Use Industries
7. Global Medical High Pressure Syringe Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Medical High Pressure Syringe Total Addressable Market (TAM) Analysis for the Market
9. Medical High Pressure Syringe Market Segmentation
10. Medical High Pressure Syringe Market Regional and Country Analysis
11. Asia-Pacific Medical High Pressure Syringe Market
12. China Medical High Pressure Syringe Market
13. India Medical High Pressure Syringe Market
14. Japan Medical High Pressure Syringe Market
15. Australia Medical High Pressure Syringe Market
16. Indonesia Medical High Pressure Syringe Market
17. South Korea Medical High Pressure Syringe Market
18. Taiwan Medical High Pressure Syringe Market
19. South East Asia Medical High Pressure Syringe Market
20. Western Europe Medical High Pressure Syringe Market
21. UK Medical High Pressure Syringe Market
22. Germany Medical High Pressure Syringe Market
23. France Medical High Pressure Syringe Market
24. Italy Medical High Pressure Syringe Market
25. Spain Medical High Pressure Syringe Market
26. Eastern Europe Medical High Pressure Syringe Market
27. Russia Medical High Pressure Syringe Market
28. North America Medical High Pressure Syringe Market
29. USA Medical High Pressure Syringe Market
30. Canada Medical High Pressure Syringe Market
31. South America Medical High Pressure Syringe Market
32. Brazil Medical High Pressure Syringe Market
33. Middle East Medical High Pressure Syringe Market
34. Africa Medical High Pressure Syringe Market
36. Medical High Pressure Syringe Market Competitive Landscape and Company Profiles
37. Medical High Pressure Syringe Market Other Major and Innovative Companies
40. Medical High Pressure Syringe Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Medical High Pressure Syringe Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses medical high pressure syringe market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for medical high pressure syringe? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The medical high pressure syringe market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: CT Injector Systems; MRI Injector Systems; Angiographic Injector Systems2) By Material: Plastic Syringes; Glass Syringes; Metal Syringe
3) By Application: Cardiology; Radiology; Diagnostic Imaging Procedures; Interventional Imaging Procedures
4) By End User: Hospitals; Diagnostic Centers; Ambulatory Surgical Centers
Subsegments:
1) By CT Injector Systems: Single-head CT Injectors; Dual-head CT Injectors; Syringeless Injectors;2) By MRI Injector Systems: MR-Compatible Injectors; Non-Ferromagnetic Injectors; Syringeless MRI Injectors
3) By Angiographic Injector Systems: Fixed Angiographic Injectors; Mobile Angiographic Injectors; Dual-syringe Injectors
Companies Mentioned: Cardinal Health Inc.; Bayer AG; Medline Industries Inc.; Becton Dickinson and Company; GE Healthcare Technologies Inc.; Terumo Corporation; Gerresheimer AG; Merit Medical Systems Inc.; MedNet GmbH; B. Braun Melsungen AG; Ulrich GmbH & Co. KG; Hawkmed (Shenzhen Hawk Medical Instrument Co. Ltd.); Kemper Medical Inc.; Smiths Medical (ICU Medical Inc.); APOLLO RT Co. Ltd.; Hindustan Syringes & Medical Devices Limited; Guerbet Group; Bracco Imaging S.p.A.; Nemoto Kyorindo Co. Ltd.; Medrad (Bayer Radiology); AngioDynamics Inc.; Shenzhen Antmed Co. Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Medical High Pressure Syringe market report include:- Cardinal Health Inc.
- Bayer AG
- Medline Industries Inc.
- Becton Dickinson and Company
- GE Healthcare Technologies Inc.
- Terumo Corporation
- Gerresheimer AG
- Merit Medical Systems Inc.
- MedNet GmbH
- B. Braun Melsungen AG
- Ulrich GmbH & Co. KG
- Hawkmed (Shenzhen Hawk Medical Instrument Co. Ltd.)
- Kemper Medical Inc.
- Smiths Medical (ICU Medical Inc.)
- APOLLO RT Co. Ltd.
- Hindustan Syringes & Medical Devices Limited
- Guerbet Group
- Bracco Imaging S.p.A.
- Nemoto Kyorindo Co. Ltd.
- Medrad (Bayer Radiology)
- AngioDynamics Inc.
- Shenzhen Antmed Co. Ltd.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.77 Billion |
| Forecasted Market Value ( USD | $ 2.4 Billion |
| Compound Annual Growth Rate | 8.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 23 |
